Clarix
Clarix503B DIGITAL

Insights · 21 CFR Part 11

21 CFR Part 11 for 503B Facilities: What the FDA Actually Checks

August 18, 2026 · 8 min read

21 CFR Part 11 governs electronic records and electronic signatures used in place of paper. For a 503B outsourcing facility, it applies the moment an electronic system creates, modifies, or signs a regulated record — which, for most facilities, means the batch record system, environmental monitoring, training, and CAPA platforms.

Part 11 does not require you to go electronic. But if you do, the system must help ensure records are trustworthy, attributable, and tamper-evident. Here is what inspectors actually focus on when they review an electronic records system.

1. Audit trail completeness (§ 11.10)

Inspectors look for a secure, computer-generated, timestamped audit trail that records every create, modify, and delete action: who did it, when, from which device, and what changed. Two things trip facilities up: audit trails that can be edited by administrators, and systems that log actions in places users can bypass. The trail should be immutable and capture the meaning of the action — not just that something changed.

2. E-signature authenticity (§ 11.50)

Every electronic signature must show the signer's printed name, the date and time, and the meaning of the signature (approval, check, release). Inspectors also verify that signatures are bound to the record and cannot be copied from one document to another. Dual-signature workflows — where a technician and a pharmacist-in-charge both sign a release — are a strong signal that the facility takes signature integrity seriously.

3. Access controls (§ 11.300)

Unique user IDs, role-based permissions, and periodic checks are the baseline. Inspectors will ask who can approve a batch, who can change a master formula, and whether terminated employees still have active accounts. Systems that enforce role gates at the workflow level — rather than relying on people to follow policy — make this easy to demonstrate.

4. Validation evidence

The FDA does not certify software. Your organization validates the system for its intended use, and inspectors will ask for the evidence: IQ/OQ/PQ protocols, test records, and a clear link between validation and the exact version of the software running in production. This is where many facilities stall — validation documentation that matches the deployed version is surprisingly rare. A vendor that ships a turnkey validation package aligned to the source version removes months of that work.

5. Record retention and retrieval

Electronic records must be retained and retrievable throughout the required period, in a format that remains readable. Inspectors will ask you to pull a specific batch record from two years ago and walk through its full lifecycle. The practical test is simple: can your system produce the complete, unaltered record on demand?

A practical self-assessment

  • Can an administrator modify or delete audit trail entries?
  • Do release signatures capture name, timestamp, and meaning — and can a signature be reused across records?
  • Are role gates enforced by the system, or by policy alone?
  • Does your validation documentation match the deployed version?
  • Can you retrieve any historical record in minutes, unaltered?

If any answer gives you pause, you are not alone — most facilities inherited systems built before Part 11 was on their radar. Our 21 CFR Part 11 explainer shows how these controls look when they are embedded in the product itself, and the e-signatures & audit trail docs cover the engineering detail.

Ready to see Part 11 controls in practice?

Clarix ships with dual e-signatures, an immutable audit trail, and a turnkey IQ/OQ/PQ package. Request a pilot.